content

Twist Bioscience and Pandion Therapeutics Expand Antibody Optimization Collaboration

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced an expanded antibody...

PCI Pharma Services Announces Major Investment to Expand Development and Manufacturing Capabilities at Tredegar, UK Site

PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, announced it has begun an expansion of its Tredegar facility in...

Sanofi Lines Up for Potential Approval of Cold Agglutinin Disease Treatment

Following positive results from a pivotal Phase III trial assessing the safety and efficacy of sutimlimab in people with primary cold agglutinin disease (CAD),...

Pistoia Alliance Report ‘Futurecasts’ a Decade of Change for Life Sciences and Healthcare

The Pistoia Alliance, a global, not-for-profit organisation that works to lower barriers to innovation in life sciences R&D, announced the publication of a new...

Switzerland partners with Bio Asia2020; seeks closer ties with Indian Lifesciences industry

Switzerland, consistently ranked no.1 in innovation, is widely known for innovation in big pharma with the presence of eminent pharma and life-sciences companies like...

Inceptua Medicines Access and Onconova Therapeutics Announce Pre-approval Access Collaboration for Rigosertib in Selected Countries Outside the US

Onconova Therapeutics, Inc , a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes...

Sharp Strengthens Senior Leadership Team with Two Appointments

Sharp, a part of UDG Healthcare and a leading provider of pharmaceutical packaging and clinical services, has strengthened its senior leadership team with two...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read